ThromboTargets Corporation Company Profile

08:15 EST 11th December 2018 | BioPortfolio

Thrombotargets Corporation is an innovative US Biotech Company based on Drug Discovery and Development of new medicines focused on advances in recombinant DNA and small molecules. Thrombotargets´s programs leverage the company’s hemostasis expertise and are focused on inherited and acquired Hemorrhagic and Thrombotic disorders. Furthermore, Thrombotargets is developing projects in other interesting therapeutical areas as as Atherotrombotic, Cancer, Neurodegenerative and Ageing related disorders.

Thrombotargets is integrated by Thrombotargets Corporation (Durham, NC, USA.) is responsible for Drug Development and Business Management; Thrombotargets Europe (Barcelona, Spain) projected for Target Identification, Lead Validation, Lead Optimization and Biotech Libraries (Spain) for engineered targeted libraries and High Throughput Screening (HTS – PA) Services.

With a primary focus on therapeutics for Hemostasis and Thrombotic diseases, Thrombotargets´s objective is to identify, optimize and develop highly efficacious biotech small molecule leads to cover the current market needs.

Thrombotargets will achieve their objectives by operating a balanced risk business strategy: 1. Invest in our own discovery and development programs and drive these through to clinical phases before partnering the candidate with pharmaceutical companies. 2. Collaborate with the pharmaceutical industry leaders to share the investment and the rewards associated with generating market outcomes for innovative new therapies through the commercialization of BioPlatformScreenTM 3. Through the in-licensing of programs at stages of development that complement and balance our existing internal portfolio, Thombotargets leverage external innovation .

Proprietary Technology
Thrombotargets has developed and adapted to High Throughput Screening (HTS), a new family of biological assays capable to quantify simultaneously clot formation and clot lysis (Hemosta-BioPlatformScreen), total antioxidant capacity (Oxidant-BioPlatformScreen) and low-density lipoprotein modification (Athero-BioPlatformScreen). With these proven proprietary HTS Platforms named BioPlatformScreenTM, the Thrombotargets is creating a continuously novel and promising pipeline. Presently, two of Thrombotargets most innovative drug candidates, TT-103MH, a novel antihemorrhagic human recombinant protein to be use topically, and TT-105, a novel anticoagulant monoclonal antibody, are undergoing Preclinical trials; these programs will begin Phase I clinical trials Q4, 2007. Furthermore we have begun a new antifibrinolytic program (TT-111 and TT-112) in collaboration with ASINEX, Russia due to results in the exploitation of our BioplatformScreenTM Technology. Recently, two new Anti-coagulant (TT-123 and TT-124) found out through libraries of small molecules in association with Specs, Delft (Netherlands).

Download Detailed Profile

Full corporate profile including details on recent and anticipated activities, current alliances, intellectual property status, products, financing strategy and investors. Also details on senior management, board of directors and scientific advisory board can be viewed: Download Corporate Information PDF


Press Releases listed on BioPortfolio

Corporate Web Site Content

Home | Corporate | Pipeline | Discovery and Development | Partnering | Investors | News | Contact.


2530 Meridian Parkway, Suite 3024
North Carolina
United States of America


Phone: +1 919 806 4254
Fax: +1 919 806 4870

News Articles [78 Associated News Articles listed on BioPortfolio]

Orion Corporation: Managers' transactions - EVK-Capital Oy

ORION CORPORATION      MANAGERS' TRANSACTIONS 31 MAY 2018 at 18.30 EEST              Orion Corporation: Managers' transactions - EVK-Capital Oy Orion Corp...

Ambu A/S: Articles of Association November 2018

  Attached the updated Articles of Association November 2018 Complete Articles of Association November 2018This announcement is distributed by West Corporation on behalf of West Corporation...

Orion Corporation: Managers' transactions - Anne Karvonen

ORION CORPORATION      MANAGERS' TRANSACTIONS 20 June 2018 at 11.45 EEST Orion Corporation: Managers' transactions - Anne Karvonen Orion Corporation has received the fo...

Orion Corporation: Managers' transactions - Nina Karvonen

ORION CORPORATION         MANAGERS' TRANSACTIONS 20 June 2018 at 12.00 EEST Orion Corporation: Managers' transactions - Nina Karvonen Orion Corporation has recei...

Mandatory notification of trade

Valborg Godal Vold, COO of Vistin Pharma ASA, and a primary insider, has on 18 September 2018 sold 50,000 shares in Vistin Pharma ASA at an average price of NOK 10.58 per share. Following this sa...

International Endeavors Corporation Hires Marketing Director

TEMECULA, Calif., June 11, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE--International Endeavors Corporation (OTC:IDVV) announces the hiring of William Vinson as Marketing Director to expand sales of t...

Arrayit Corporation and TeleChem International Inc Celebrate 25 Years in Business

Sunnyvale, Nov. 01, 2018 (GLOBE NEWSWIRE) -- Arrayit Corporation (OTC: ARYC), a life sciences and personalized medicine company, announces that management and staff are commemorating its 25-year b...

International Stem Cell Corporation Developed 3D Liver Structures

CARLSBAD, Calif., Aug. 06, 2018 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB:ISCO) ( ("ISCO" or "the Company"), a California-based clinical stage bio...

PubMed Articles [0 Results]


Clinical Trials [0 Results]


Companies [179 Associated Companies listed on BioPortfolio]

ThromboTargets Corporation

Thrombotargets Corporation is an innovative US Biotech Company based on Drug Discovery and Development of new medicines focused on advances in recombinant DNA and small molecules. Thrombotargets´s pr...

Toshiba Corporation

Toshiba Medical Systems Corporation is a leading worldwide provider of medical diagnostic imaging systems and comprehensive medical solutions, such as CT, X-ray and vascular, ultr...

Bruker Daltonics

Bruker Corporation is a leading provider of high-performance scientific instruments and solutions for molecular and materials research, as well as for industrial and applied analy...

Protective Life Corporation

Protective Life Corporation provides financial services through the production, distribution and administration of insurance and investment products throughout the U.S. The compan...

NEC Corporation of America

NEC Corporation of America (NEC) is a leading technology integrator providing solutions that improve the way people work and communicate. NEC delivers integrated Solutions for Soc...

More Information about "ThromboTargets Corporation" on BioPortfolio

We have published hundreds of ThromboTargets Corporation news stories on BioPortfolio along with dozens of ThromboTargets Corporation Clinical Trials and PubMed Articles about ThromboTargets Corporation for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of ThromboTargets Corporation Companies in our database. You can also find out about relevant ThromboTargets Corporation Drugs and Medications on this site too.

Quick Search


Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Corporate Database Quicklinks

Searches Linking to this Company Record